Cystic fibrosis hetero-and homozygosity is associated with inhibition of breast cancer growth

Nature Medicine

Volumn 2, Issue 5, 1996, Pages 593-596

  Abraham, Edward H ^a   Vos, Petra ^a   Kahn, Julia ^b   Grubman, Shelley A ^c   Jefferson, Douglas M ^c   Ding, Ivan ^a   Okunieff, Paul ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c TUFTS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE;

ANIMAL EXPERIMENT; ARTICLE; BREAST CANCER; CANCER INHIBITION; CYSTIC FIBROSIS; FEMALE; HUMAN; HUMAN CELL; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ADENOSINE TRIPHOSPHATE; ANIMALS; CYSTIC FIBROSIS; CYSTIC FIBROSIS TRANSMEMBRANE CONDUCTANCE REGULATOR; HETEROZYGOTE; HOMOZYGOTE; HUMANS; MAMMARY NEOPLASMS, EXPERIMENTAL; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT;

EID: 0029962277     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm0596-593     Document Type: Article

References (22)

1. Abraham, E.H. et al. CFTR: An ATP channel with associated transmembrane ATP cycle. J. Gen. Physiol. 100, 145a (1992).
2. Reisin, I.L. et al. The cystic fibrosis transmembrane conductance regulator is a dual ATP and chloride channel. J. Biol. Chem. 269, 20584-20591 (1994).
3. Schwiebert, E.M. et al. CFTR regulates outwardly rectifying chloride channels through an autocrine mechanism involving ATP. Cell 81, 1063-1073 (1995).
4. Rapaport, E. & Fontaine, J. Anticancer activities of adenine nucleotides in mice are mediated through expansion of erythrocyte ATP pools. Proc. Natl. Acad. Sci. USA 86, 1662-1666 (1989).
5. Rapaport, E., Fishman, R.F. & Gercel, C. Growth inhibition of human tumor cells in soft-agar cultures by treatment with low levels of adenosine 5′-triphosphate. Cancer Res. 43, 4402-4406 (1983).
6. 31P NMR, laser Doppler flowmetry, and intradermal angiogenesis. Radiat. Oncol. Invest. 1, 346-360 (1994).
7. Froio, J., Abraham, E.H., Soni, R., Epstein, A. & Okunieff, P. Effect of intraperitoneal ATP on tumor growth and bone marrow radiation tolerance. Acta Oncol. 34, 419-422 (1995).
8. Neglia, J.P. et al. The risk of cancer among patients with cystic fibrosis. N. Engl. J. Med. 332, 494-499 (1995).
9. Warren, N. et al. Frequency of carriers of cystic fibrosis gene among patients with myeloid malignancy and melanoma. Br. Med. J. 302, 760-761 (1991).
10. Siegel, D., Irving, N.G., Friedman, J.M. & Wainwright, B.J. Localization of the cystic fibrosis transmembrane conductance regulator (Cftr) to mouse chromosome 6. Cytogenet. Cell Genet. 61, 184-185 (1992).
11. Takahashi, Y. et al. Mapping of the nu gene using congenic nude strains and in situ hybridization. J. Exp. Med. 175, 873-876 (1992).
12. McLesky, S., Ding, I., Lippman, M.E. & Kern, F.G. MDA-MB-134 breast carcinoma cells overexpress FGF receptors and is growth-inhibited by FGF ligands. Cancer Res. 54, 523-530 (1994).
13. Kern, F. et al. Transfected MCF-7 cells as a model for breast cancer progression. Breast Cancer Res. Treat. 31, 153-165 (1994).
14. McLeskey, S.W. et al. Fibroblast growth factor 4 transfection of MCF-7 cells produces cell lines that are tumorigenic and metastatic in ovariectomized or tamoxifen-treated athymic nude mice. Cancer Res. 53, 2168-2177 (1993).
15. Rapaport, E. Anticancer activities of adenine nucleotides in tumor bearing hosts. Drug Dev. Res. 28, 428-431 (1993).
16. 2-purinergic receptor agonists inhibit the growth of androgen-independent prostate carcinoma cells. J. Clin. Invest. 89, 191-196 (1992).
17. Abraham, E.H. et al. The multidrug resistance (mdr1) gene product functions as an ATP channel. Proc. Natl. Acad. Sci. USA 90, 312-316 (1993).
18. Jenkins, H.A., Summan, M., Shiel, N., Jones, M. & Braganza, J.M. Raised adenine nucleotide concentrations in erythrocytes of patients with cystic fibrosis. Biochem. Soc. Trans. 21, 326S (1993).
19. Schiavi, S.C. et al. Biosynthetic and growth abnormalities are associated with high-level expression of CFTR in heterologous cells. Am. J. Physiol. 270, C341-C351 (1996).
20. Koller, B.H. et al. Toward an animal model of cystic fibrosis: Targeted interruption of exon 10 of the cystic fibrosis transmembrane regulator gene in embryonic stem cells. Proc. Natl. Acad. Sci. USA 88, 10730-10734 (1991).
21. Snouwaert, J.N. et al. An animal model for cystic fibrosis made by gene targeting. Science 257, 1083-1088 (1992).
22. Denning, G.M. et al. Procession of mutant cystic fibrosis transmembrane conductance regulator is temperature-sensitive. Nature 358, 761-764 (1992).